Vasamed (VSMD) Stock Price, News & Analysis

Company Overview

Vasamed, Inc. (OTCMKTS: VSMD) is a development‐stage medical device company dedicated to creating advanced vascular therapies for chronic cerebrovascular and peripheral arterial disease. Headquartered in Charlottesville, Virginia, the company focuses on implantable technologies designed to improve vessel healing and maintain blood flow in patients undergoing neurovascular and peripheral vascular interventions.

The company’s lead program is a drug‐eluting intracranial stent system under development for treatment of ischemic and hemorrhagic stroke. In addition, Vasamed is advancing a sutureless vascular anastomosis device aimed at simplifying bypass procedures and reducing operative time in peripheral arterial disease. Complementing these core platforms, the company is exploring novel vascular grafts and patch materials engineered to enhance biocompatibility and minimize restenosis.

Vasamed’s pipeline progress is supported by preclinical data and ongoing preparation for regulatory submissions, including planned 510(k) filings in the United States and CE mark applications in Europe. The company collaborates with leading academic medical centers for device testing and leverages its internal expertise in materials science and vascular biology to refine product performance. These efforts position Vasamed to address substantial unmet needs in minimally invasive neuroendovascular and peripheral vascular care.

Under the guidance of a management team experienced in medical device development and regulatory affairs, Vasamed is building operational capabilities and establishing strategic partnerships for manufacturing and clinical evaluation. A scientific advisory board comprising specialists in neurointerventional surgery and vascular research provides additional technical oversight, steering the company’s technologies toward commercial readiness.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 7/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:VSMD
• CIK: N/A
• Web: www.vasamed.com
• Phone: (952) 944-5857
• Fax: 952-944-6022
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A